Short answer
MYOMO, INC. (MYO) filed its Q3 2026 10-Q quarterly report on Nov 9, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $12M (up 22.2% year over year) with net income of −$4M.
Q3 2026 key financials · XBRL
- Revenue
- $12M
- +22.2% YoY · +5.3% QoQ
- Net income
- −$4M
- −15.6% YoY · −5.3% QoQ
- Operating margin
- -14.0%
- Gross margin
- 71.3%
- EPS (diluted)
- −$0.09
- −12.5% YoY · +10.0% QoQ
Source: XBRL data from the MYOMO, INC. (MYO) Q3 2026 10-Q on SEC EDGAR. USD.
MYOMO, INC. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $12.3M, up 22% YoY from $10.1M, driven by higher units and average selling price
- Gross margin 71.3% vs 63.8% YoY, reflecting manufacturing cost reductions and higher average selling price
- Best channel: direct billing $9.0M vs $7.3M; lowest: VA $0.3M vs $0.1M
- Cash, equivalents and short-term investments $11.9M vs $18.4M at December 31, 2025; operating cash use $5.4M
- 2026 focus: MyoConnect and O&P referrals, lower advertising dependence, fixed-expense growth limited to half revenue growth
Risk Factors
- New tariff exposure: 2026 imports expected to reduce gross margin by less than 100 basis points, with future policies uncertain
- Regulatory risk: Medicaid and Medicare reimbursement policy changes could adversely affect product economics
- International expansion risk: Planned distribution faces limited experience with foreign regulatory environments
- Operational risk: O&P channel growth may strain management, suppliers, infrastructure, systems, processes and controls
- Financial risk: Currency fluctuations could affect results as international operations expand
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MYOMO, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.